| abstract |
The present application provides processes for preparing (R)-4-(3-((S)-1-(4-amino-3nmethyl-iH-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-5-chloro-2-ethoxy-6nfluorophenyl)pyrrolidin-2-one, which is useful as an inhibitor phosphoinositide 3-kinasendelta (PI3K), as well as a salt form and intermediates related thereto. |